To analyze cell surface murine leukemia virus gag protein expression, we have prepared monoclonal antibodies against the spontaneous AKR T lymphoma KKT-2. One of these antibodies, 43-13, detects an AKR-specific viral p12 determinant. A second monoclonal antibody, 43-17, detects a novel murine leukemia virus-related antigen found on glycosylated gag polyproteins (gp95gag, gp85gag, and gp55gag) on the surface of cells infected with and producing ecotropic endogenous viruses, but does not detect antigens within these virions. The 43-17 antibody immunoprecipitates the precursor of the cell surface gag protein whether in its glycosylated or unglycosylated state, but does not detect the cytoplasmic precursor of the virion gag proteins (Pr05gag). Based on these findings, we have localized the 43-17 determinant to the unique amino-terminal part of the glycosylated gag polyprotein (the L domain). We have determined that gp95gag contains L-p15-pl2-p30-plO determinants, whereas gp859ag lacks the carboxyterminal plO determinant, and gp55gag lacks both p30 and plO carboxy terminal determinants. Analysis of cell surface gag expression with the 43-17 antibody leads us to propose that the L domain plays a crucial role in (i) the insertion and orientation of murine leukemia virus gag polyproteins in the cell membrane and (ii) the relative abundance of expression of AKR leukemia virus versus Moloney murine leukemia virus glycosylated gag polyproteins in infected cells.
The murine leukemia virus (MuLV) gag genes are initially transcribed from a full-length (35S) RNA species (25, 65) . One of the translation products of this message is a 65,000-molecular-weight polyprotein (Pr65,""() (36, 53, 64) which contains the virion gag structural proteins in the order NH2-p15-p12-p30-p10-COOH (3, 44) . This polyprotein is subsequently phosphorylated within p12 (50) and cleaved sequentially to release the individual gag peptides for packaging into the virion core (1, 53, 64) .
The discovery of a glycosylated form of the gag polyprotein at the surface of AKR lymphomas (31, 63) led to the recognition of a second pathway of gag gene processing. In Moloney MuLV-infected cells treated with tunicamycin, a 75,000-molecular-weight polyprotein (Pr75`"`I) is detected which has been implicated as the precursor of glycosylated gag polyproteins (9, 15, 50) . Tryptic peptide mapping has shown that Pr65`1`1' and Pr752"'J share all gag virion structural proteins, but that Pr75(JS" contains a unique amino-terminal portion of 5,000 to 7,000 molecular weight termed "L" because it contains the leader (10, 48, 49) or left-hand sequence. However, the precise role of the L domain in gag protein processing and cell surface expression is not known.
To investigate further the mechanisms of cell surface gag expression, we have prepared monoclonal antibodies to cell surface gag antigens of spontaneous AKR lymphomas by using xenogeneic immunizations. In this paper we report the isolation and characterization of a rat monoclonal antibody, , which detects an antigenic determinant localized to or dependent upon the unique amino-terminal L domain of the glycosylated gag polyprotein (10, 49) . Using the 43-17 antibody, we present evidence that the L domain plays a crucial Butcher, Stanford University), are maintained by serial in vivo passage in irradiated (400 rads) AKR/J mice.
Viruses. The characteristics of the cloned viruses in this study are summarized in Table 2 . Ecotropic viruses are maintained in the 1116A feral mouse fibroblast cell line (obtained from T. Pincus, Vanderbilt University, Nashville, Tenn.); dualtropic and xenotropic viruses are maintained in the CCL64 mink lung fibroblast cell line (from J. Hartley, National Institutes of Health). Fibroblast cell lines are grown in culture in our laboratory in minimal essential medium (GIBCO) supplemented with 10% fetal calf serum. The cloned AKR L-1, WN1802N, WN1802B, and AKR-6 viruses were obtained from T. Pincus. BL/Ka(N), BL/Ka(B), BL/Ka(X), and RadLV/VL3 viruses were provided by M. Lieberman. Cloned MCF 247 virus was obtained from J. Hartley.
Virions were purified from the supernatant fluids of virusproducing fibroblasts and lymphoma cells by Sepharose 4B chromatography (35) lymphoid cells. Only two of these hybrids, designated 43-13 and 43-17, were negative on all lymphoid cells (data not shown). These two hybridoma lines were cloned at limiting dilution and grown to larger volume for further characterization of their monoclonal antibodies.
With the FACS, the two hybridomas were screened against a panel of tumors representing a variety of different cell types and modes of induction ( Table 1 ). The 43-13 antibody is specific for AKR lymphomas; no binding was observed for any other tumor regardless of origin. In contrast, the 43-17 hybridoma detects an antigen found on a variety of tumors in addition to those of AKR origin. The highest level of 43-17-detected antigen is on the myeloma NS-1. Only three cell lines tested were totally negative for the 43-17 antigen. Two of these are radiation-induced lymphomas which do not produce detectable MuLV virions: L691 and BL/RL-12-NP (33) . Surprisingly, the spontaneous AKR lymphoma BW5147 was also negative for both the 43-13 and 43-17 antigens. However, this cell line has been maintained for years in culture and no longer produces detectable levels of MuLV (33) .
To investigate further the relationship between virusencoded antigens and the expression of 43-13 and 43-17 antigens, the same tumor lines were stained with a heterologous rabbit anti-p30 serum. The occurrence of the 43-13 and 43-17 antigens was found to correlate closely with that of p30 expression on the cell surface ( Table 1 ). All cell lines which are 43-17 positive are also positive for p30, although there are quantitative differences in the expression of the two antigens. These findings are supported by immunoprecipitation with the 43-13 and 43-17 antibodies of molecules of approximately 95,000, 85,000, and 55,000 molecular weight from 1251-surface-labeled KKT-2 cells (Fig. 1) . The two higher-molecular-weight proteins are precipitated also by the anti-p30 serum and thus correspond to the glycosylated gag polyproteins (gp95gag and gp85gag) previously identified on spontaneous AKR lymphomas (30, 55, 63 (Fig. 2) , the 43-13 antibody was found to precipitate both the precursor of the virion gag structural proteins (Pr652"og) and the 180,000-molecular-weight gag-pol precursor (Pr1809`''-""'). antibody also immunoprecipitates p12-related peptides from metabolically labeled AKR virus-infected cells and their supernatants (data not shown).
In contrast, the 43 (Fig. 4) . In contrast to the three cell surface gag polyproteins found on untreated cells (gp95 "', gp852"'g, and gp55"'i'), endo F treatment produces three deglycosylated products with increased electrophoretic mobility protein from tunicamycin-treated KKT-2 cells with 43-17 and anti-plO antibodies suggest that this protein is the precursor of the glycosylated gag polyproteins. In analogy to P0751'"l in the Moloney MuLV system, we have termed this protein Pr85g"l. These findings are in contrast with those of Ledbetter (29) , who reported that a 75,000-molecularweight protein is the precursor of the glycosylated gag in AKR lymphoma cells. We have also detected a 75,000-molecular-weight protein in AKR tumors with 43-13 and anti-plO antibodies, but not with (Fig. 2) (13, 43, 45) , this suggests that the expression of the 43-13 and 43-17 antigens is related to expression of either AKR-specific endogenous ecotropic gag gene products or of endogenous ecotropic gag gene products in general . ' Median fluorescence above background staining was standardized to a fluorescence gain of 1. Background staining was determined independently for each cell line using as a first stage control either a nonbinding monoclonal antibody of irrelevant specificity (for 43-13 and 43-17) or normal goat serum (for anti-gp7O and anti-p30 sera).
"The ratio of anti-p30 fluorescence to anti-gp7O fluorescence on the same cell line. ' The ratio of fluorescence to anti-gp7O fluorescence on the same cell line.
Our finding that cloned Moloney virus infection of 1116A does not lead to cell surface expression is in contrast with the high level of and p30 antigens on some of our currently maintained in vitro Moloney tumors (Table 1) . However, all of the Moloney tumors tested arose in mouse strains (BALB/c or a) in which spontaneous expression of endogenous gag gene products is common (40) . Thus, it is possible that the p30 and 43-17 antigens detected on these Moloney tumors may reflect in vitro activation of endogenous ecotropic virus gag genes rather than cell surface expression of Moloney virus gag-related proteins. To test this hypothesis, we compared gp7O and p30 expression on cells of C57L or C57BL background infected with or transformed by several murine retroviruses, including Moloney virus (Table 4) . These mouse strains were chosen because they do not spontaneously activate endogenous ecotropic virus (27) or gag-related proteins (40) in culture. When normalized for gp70 expression, it is evident that cells infected by Moloney virus have a 5-to 10-fold lower amount of cell surface gag gene products as compared with those infected by AKR-type viruses (Table 4) . DISCUSSION 43-17 antibody detects an antigenic determinant unique to glycosylated gag polyproteins. We have prepared monoclonal antibodies reactive with MuLV gag polyproteins in AKR lymphomas. One of these antibodies, 43-13, detects an AKR-specific p12-related determinant found both within the virion core and as part of cell surface glycosylated gag polyproteins. In contrast, the 43-17 antibody detects an antigen specific for glycosylated gag polyproteins of endogenous ecotropic viruses. The 43-17 antigen is not found within the virion or as part of the internal precursor of the viral core proteins (Pr65gag), but is present on the precursor of the glycosylated gag polyproteins found in tunicamycin or endo F-treated cells. Since the MuLV glycosylated gag polyproteins have been shown to contain only three Nlinked carbohydrate groups (47) , the experiments with tunicamycin and endo F almost certainly rule out the possibility that the 43-17 antibody detects a carbohydrate determinant. Based on the presence of the antigen on the precursor of the glycosylated gag but not on Pr65 , we propose that the antigenic determinant is localized to or dependent on the unique amino terminus of the glycosylated gag polyprotein (L domain).
L domain may play a role in membrane insertion and cell surface expression of glycosylated gag polyproteins. Although most cell surface proteins are anchored in the membrane via a hydrophobic carboxyl terminus (32), the carboxyl terminus (PlO and p30) of most retroviruses is highly polar (4, 19, 42) . However, the amino terminus of the gag polyprotein (including both a putative leader [signal] sequence in L and p15) is hydrophobic (2, 50, 57) . Since the 43-17 antibody binds to the surface of intact cells via the unique amino terminus of the cell surface gag polyprotein (L), all or part of the L domain of the glycosylated gag should be retained after entry into the rough endoplasmic reticulum, in contrast to classical leader ("signal") peptides, which are cleaved during translocation (5, 8) . Thus, it is possible that retention of hydrophobic L or p15 sequences or both after entry into the rough endoplasmic reticulum might allow for insertion of the glycosylated gag polyprotein into the membrane via the amino terminus. A similar mechanism has been proposed for insertion of the sucrase-isomaltase enzyme complex into the intestinal brush border membrane (6) . The Pr65gag polyprotein has an added hydrophobic segment due to a posttranslational myristyl amino-terminal acylation of the first amino acid, glycine (20) . We do not know if the L domain is similarly fatty acid acylated.
The strongest support for the hypothesis that cell surface gag polyproteins are anchored in the membrane via the amino terminus is provided by the identification of three cell surface forms of the glycosylated gag which differ at the carboxyl terminus: (i) gp95gag, which contains L (43-17), p12 , p30, and plO determinants (29, 31) ; (ii) gp85gag, which contains L, p12, and p30, but not p10, determinants (62) ; and (iii) the newly identified gp55gag, which contains L and p12, but not p30 or plO determinants (Kooistra et al., manuscript in preparation). Naso (54) predicts an open reading frame of 333 nucleotides 5' to the initiating AUG triplet of the p15 gag protein. Although there are three additional potential initiation sites in the leader region which could serve for translation of the glycosylated gag polyprotein, none of these is in the correct reading frame. This suggests that RNA processing may be necessary to create a spliced mRNA from which the Moloney virus glycosylated gag can be translated or that an unusual initiation site (e.g., GTG) may be used (51, 54) . Saris et al. (47) have analyzed peptide maps of Moloney MuLV gp80(a9 and PrO5gag and conclude that 7 kilodaltons (kDa) of additional amino acids reside at the amino terminus of gp8Qgag. They proposed that this unique sequence is a leader sequence which may be greater than 7 kDa in size, and which replaces part of the p15 sequence as well. In fact, they propose the amino-terminal unique sequence to be 10 to 20 kDa (47), a size approaching the additional L domain described here. We estimate the AKR L domain to be 18 to 20 kDa on the basis of the size differences of the glycosylated and nonglycosylated forms of surface pathway gag polyproteins and internal pathway gag polyproteins. Thus unglycosylated gp95gag is -85 kDa, -20 kDa greater than Pr659ag; unglycosylated gp85gag is -75 kDa, -18 kDa greater than p15 plus p12 plus p30; and unglycosylated gp55gag is -45 kDa, -18 kDa greater than p15 plus p12 (gp55gag lacks both plO and p30 determinants).
We have examined the published DNA sequences 5' of the p15 ATG translation start site for both Moloney MuLV (54) and AKR leukemia virus (14, 21) . There is no continuous open reading frame which could encode an 18-to 20-kDa peptide, although it is possible to construct potential spliced messages which encode this size polypeptide using the 5' long terminal repeat of AKR (66, 67) .
